Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

Presentation TCT 2019

TCT 2: Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement in Moderate Risk Patients: A Pooled PARTNER 2 Trial and Registry Study

Presenter: Katherine Chau

September 28, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Presentation TCT 2019

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Presenter: Philippe Pibarot

September 26, 2019

Presentation TCT 2019

Case-Based Learning: Paravalvular Mitral Prosthetic Regurgitation

Presenter: Nishath Quader

September 26, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Daily News

Early Signs Positive for Tendyne TMVR in Severe MAC

Caitlin E. Cox

September 11, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

Advertisement

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

TCT 2: Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement in Moderate Risk Patients: A Pooled PARTNER 2 Trial and Registry Study

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

TCT 2019 Day Two: Transcatheter Valves, New and Old

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Case-Based Learning: Paravalvular Mitral Prosthetic Regurgitation

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

What I Am Most Looking Forward to at TCT 2019

Early Signs Positive for Tendyne TMVR in Severe MAC

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content